Cite
Factors associated with mortality among persistently viraemic triple-antiretroviral-class-experienced patients receiving antiretroviral therapy in the HIV Outpatient Study (HOPS).
MLA
Palella, Frank J., et al. “Factors Associated with Mortality among Persistently Viraemic Triple-Antiretroviral-Class-Experienced Patients Receiving Antiretroviral Therapy in the HIV Outpatient Study (HOPS).” Journal of Antimicrobial Chemotherapy (JAC), vol. 69, no. 10, Oct. 2014, pp. 2826–34. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=asx&AN=98636590&authtype=sso&custid=ns315887.
APA
Palella, F. J., Armon, C., Buchacz, K., Chmiel, J. S., Novak, R. M., D’Aquila, R. T., & Brooks, J. T. (2014). Factors associated with mortality among persistently viraemic triple-antiretroviral-class-experienced patients receiving antiretroviral therapy in the HIV Outpatient Study (HOPS). Journal of Antimicrobial Chemotherapy (JAC), 69(10), 2826–2834.
Chicago
Palella, Frank J., Carl Armon, Kate Buchacz, Joan S. Chmiel, Richard M. Novak, Richard T. D’Aquila, and John T. Brooks. 2014. “Factors Associated with Mortality among Persistently Viraemic Triple-Antiretroviral-Class-Experienced Patients Receiving Antiretroviral Therapy in the HIV Outpatient Study (HOPS).” Journal of Antimicrobial Chemotherapy (JAC) 69 (10): 2826–34. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=asx&AN=98636590&authtype=sso&custid=ns315887.